Haleon (HLN)

Sector:

Pharma and Biotech

Index:

FTSE 100

414.80p
   
  • Change Today:
      0.40p
  • 52 Week High: 417.10
  • 52 Week Low: 320.80
  • Currency: UK Pounds
  • Shares Issued: 9,000m
  • Volume: 1,105,648
  • Market Cap: £37,334m
  • Beta: 0.01

Morgan Stanley upgrades Haleon on sector leading exposure to defensive product categories

By Alexander Bueso

Date: Friday 09 May 2025

LONDON (ShareCast) - (Sharecast News) - Analysts at Morgan Stanley upgraded their recommendation for shares of consumer healthcare outfit Haleon.
To back up their move, they pointed to the company's leading exposure in defensive categories, as well as the now greater clarity on margin expansion.

Hence, the analysts said that they now saw a path towards a high single digit compound annual growth rate for its earnings per share between 2026-30 - which was ahead of its sector peers.

Combined with the uncertain macroeconomic backdrop, they judged the company's shares to be an "attractive defensive play".

They also hiked their target price for the shares from 400.0p to 425.0p.



Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Haleon Market Data

Currency UK Pounds
Share Price 414.80p
Change Today 0.40p
% Change 0.10 %
52 Week High 417.10
52 Week Low 320.80
Volume 1,105,648
Shares Issued 9,000m
Market Cap £37,334m
Beta 0.01

Haleon Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
79.97% below the market average79.97% below the market average79.97% below the market average79.97% below the market average79.97% below the market average
56.52% below the sector average56.52% below the sector average56.52% below the sector average56.52% below the sector average56.52% below the sector average
Price Trend
73.08% above the market average73.08% above the market average73.08% above the market average73.08% above the market average73.08% above the market average
73.91% above the sector average73.91% above the sector average73.91% above the sector average73.91% above the sector average73.91% above the sector average
Income
11.75% below the market average11.75% below the market average11.75% below the market average11.75% below the market average11.75% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Growth
17.05% below the market average17.05% below the market average17.05% below the market average17.05% below the market average17.05% below the market average
53.33% below the sector average53.33% below the sector average53.33% below the sector average53.33% below the sector average53.33% below the sector average

Haleon Dividends

  Latest Previous
  Final Interim
Ex-Div 24-Apr-25 15-Aug-24
Paid 05-Jun-25 19-Sep-24
Amount 4.60p 2.00p

Trades for 03-Jun-2025

Time Volume / Share Price
09:26 270 @ 414.80p
09:26 837 @ 414.80p
09:26 559 @ 414.80p
09:26 48 @ 414.80p
09:26 1,637 @ 414.70p

Haleon Key Personnel

CEO Brian McNamara
CFO Dawn Allen

Top of Page